The sudeep pharma share price has become a hot topic for many investors, especially after its strong financial numbers and steady business growth. In this article, we explain everything in simple language, We will also cover sudeep pharma owner, sudeep pharma turnover, sudeep pharma IPO, sudeep pharma share price today, sudeep pharma share price tomorrow, sudeep pharma share price target from 2025 to 2030.
About the Sudeep Pharma
Sudeep Pharma is well known company that makes mineral based element used in medicines, nutrition products, and health supplements. Their products include Calcium, Magnesium, and Iron ingredients that are used by global companies.
Key Highlights Sudeep Pharma
- Serves 1,100+ customers in 100+ countries
- Used by global brands like Pfizer, Merck, Danone
- Strong manufacturing units in Vadodara
Who is the owner of Sudeep Pharma?
The company owner is Sujit Bhayani and promoted by a group of experienced founders who have been working in the pharma ingredients industry for many years. Their strong leadership has helped the company grow worldwide.
What Is The Sudeep Pharma Turnover
What is the valuation of Sudeep Pharma
| Metric | Value |
|---|---|
| Market Cap | ₹ 6,698 Cr. |
| Current Price | ₹ — |
| High / Low | ₹ — / — |
| Stock P/E | 48.3 |
| Book Value | ₹ — |
| Dividend Yield | — % |
| ROCE | 35.6% |
| ROE | 32.8% |
| Face Value | ₹ 1.00 |
| PEG Ratio | 1.19 |
| No. Eq. Shares | 11.1 Cr. |
| Asset Turnover | 0.82 |
| Debt to Equity | 0.28 |
| Debt | ₹ 140 Cr. |
| Total Assets | ₹ 717 Cr. |
| Industry PE | 21.6 |
| Free Cash Flow | ₹ -15.2 Cr. |
| EPS | ₹ 14.3 |
Sudeep Pharma IPO Details
Investors became more interested after the Sudeep Pharma IPO, which attracted good attention.
- ROCE: 35.6%
- ROE: 32.8%
- Debt-to-Equity: 0.28
- Free Cash Flow: ₹-15.2 Cr (needs improvement)
Sudeep Pharma Share Price Today
The sudeep pharma share price today reflects strong investor confidence due to High ROE and ROCE, Growing turnover, Global customer base.
Sudeep Pharma Share Price Tomorrow
The sudeep pharma share price tomorrow may show mild movement based on Market mood
Pharma sector trends, Global demand for mineral ingredients, Usually, stable companies show steady price movement instead of sudden jumps.
Sudeep Pharma Share Price Target
Here are simple, easy to understand future targets for long term investors. These are illustrative targets based on financial strength, PE ratio, ROE, industry growth, and business expansion.
Sudeep Pharma Share Price Target 2025
The End of 2025, Sudeep Pharma Share Price Target Minimum: ₹650, Maximum: ₹900
Reason: Strong demand in pharma raw materials + good export business.
Sudeep Pharma Share Price Target 2026
by 2026, Sudeep Pharma Share Price Target Minimum: ₹800, Maximum: ₹1,150
Reason: Margin improvement and expanding customer base.
Sudeep Pharma Share Price Target 2027
by 2027, Sudeep Pharma Share Price Target Minimum: ₹1,050, Maximum: ₹1,400
Reason: Better manufacturing capacity and higher global orders.
Sudeep Pharma Share Price Target 2028
by 2028, Sudeep Pharma Share Price Target Minimum: ₹1,350, Maximum: ₹1,750
Reason: Strong brand presence + higher ROCE & ROE.
Sudeep Pharma Share Price Target 2029
by 2029, Sudeep Pharma Share Price Target Minimum: ₹1,600, Maximum: ₹2,100
Reason: Industry leadership in mineral ingredients.
Sudeep Pharma Share Price Target 2030
by 2030, Sudeep Pharma Share Price Target Minimum: ₹1,950, Maximum: ₹2,500
Reason: Long-term compounding + global expansion + new product lines.
Why the Sudeep Pharma Share Price May Keep Growing
- High return on equity ROE 32.8%
- High return on capital employed ROCE 35.6%
- Stable demand for mineral ingredients.
- Global customer relationships.
- Low debt levels.
Because of these strengths the sudeep pharma share price may continue to grow steadily in the long run.
Conclusion
The sudeep pharma share price is supported by strong financials global business presence and a promising industry. For long term investors, it may be a good compounding stock if financial discipline continues.
What is The Sudeep Pharma Asset Turnover Ratio
Sudeep Pharma Asset Turnover Ratio is 0.82